Internal Sample Preparation, Small Size and Rapid Results Differentiate the FireflyDX Systems, says ExcitePCR’s CEO, Lyle Probst, During a BioWatch Panel

ExcitePCR’s President & CEO, Lyle Probst, describes how small the company’s forthcoming FireflyDX-Portable will be during a BioWatch Panel Discussion on Monday, September 18, 2017 at the National Acad

FireflyDX products will deliver the ability to incorporate sample prep within the entire PCR process. This allows caregivers, first responders, animal health workers and others to have extremely accurate results within 30 minutes or less from the moment of sample capture to PCR-derived results.

One of the biggest barriers to delivering rapid care during an biological outbreak is about to be eliminated, said Lyle Probst, President, CEO and Founder of ExcitePCR™.

When asked what makes ExcitePCR’s FireflyDX™ technologies different than other pathogen detection solutions, Probst said, “Sample preparation takes place inside our FireflyDX systems, which means our customers can go from sample capture to answer in 30 minutes or less. On top of that, the FireflyDX devices are small, portable PCR-based units which can be used virtually anywhere around the world. These are just some of the things that set our pathogen detection systems apart from other solutions.”

Later Probst explained, “The reason why this is important is because whenever we experience the beginnings of an outbreak, such as Zika or Ebola or influenza or any other biohazard, rapid identification of who is or isn’t infected is crucial to delivering proper treatment and minimizing the spread of an infectious disease. But one of the biggest barriers to delivering rapid care is (and always has been) preparing samples so they can be tested, quickly and accurately. And this is especially a problem in the field at the…

Article Source…

Leave a Reply

Your email address will not be published. Required fields are marked *